TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

Accumulating evidence indicates that immune checkpoint inhibitors (ICIs) can restore CD8(+) cytotoxic T lymphocyte (CTL) functions in preclinical models of acute myeloid leukemia (AML). However, ICIs targeting programmed cell death 1 (PDCD1, best known as PD-1) and cytotoxic T lymphocyte-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakova, Jana, Truxova, Iva, Holicek, Peter, Salek, Cyril, Hensler, Michal, Kasikova, Lenka, Pasulka, Josef, Holubova, Monika, Kovar, Marek, Lysak, Daniel, Kline, Justin P., Racil, Zdenek, Galluzzi, Lorenzo, Spisek, Radek, Fucikova, Jitka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946028/
https://www.ncbi.nlm.nih.gov/pubmed/33758676
http://dx.doi.org/10.1080/2162402X.2021.1889822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946028/
https://www.ncbi.nlm.nih.gov/pubmed/33758676
http://dx.doi.org/10.1080/2162402X.2021.1889822

Ejemplares similares